Press Releases
Selcia and Gilead Sciences Extend Liver Disease Drug Discovery...
Selcia Limited, a leading contract research organisation, announced a drug discovery collaboration agreement with Gilead Sciences, Inc. Building on an established partnership following significant progress...
Press Releases
Micell Technologies Enrolls First Patient in DESSOLVE I First-In-Human...
Micell Technologies,announced it has enrolled at Mercy Hospital in Auckland, New Zealand, the first patient in DESSOLVE I (DES with Sirolimus and a bioabsorbable pOLymer...
Press Releases
BG Medicine Announces FDA Clearance of its Galectin-3 Test...
BG Medicine, Inc., a U.S.-based life sciences company, announced that the U.S. FDA has cleared the company’s Galectin-3 test for use in conjunction with clinical...
Press Releases
NanoString Launches First Simple and Precise Approach to Detect...
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples,...
Press Releases
Merrion Pharmaceuticals Plc announces commencement of feasibility and option...
Merrion Pharmaceuticals Plc, a publicly listed product development company, announced the commencement of an oral drug delivery feasibility and option agreement with Rebel Pharmaceuticals, LLC,...
Press Releases
Abbott Announces Positive Results from Phase 2 Study of...
Abbott announced positive results from a Phase 2 dose-ranging study of atrasentan, a highly selective endothelin A receptor (ETAR) antagonist in development to help slow...
Press Releases
Reata and Abbott Announce Positive Phase 2b Study Results...
Reata Pharmaceuticals and Abbott announced data from a Phase 2b study which suggests that bardoxolone methyl, an investigational treatment for chronic kidney disease (CKD), may...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.